Wedin Madelene, Stålberg Karin Glimskär, Ottander Ulrika, Åkesson Åsa, Lindahl Gabriel, Wodlin Ninnie Borendal, Kjølhede Preben
Department of Obstetrics and Gynecology in Linköping, and Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Acta Obstet Gynecol Scand. 2025 May;104(5):976-987. doi: 10.1111/aogs.15077. Epub 2025 Mar 4.
The primary aim was to determine the occurrence of lymph ascites 4-6 weeks after surgery for endometrial cancer. Secondary aims were to assess risk factors for lymph ascites and the association with lymphedema of the legs.
This was a post hoc analysis of an observational prospective multicenter study, performed in 14 Swedish hospitals that included 235 women undergoing surgery for early-stage endometrial cancer between June 2014 and January 2018; 116 underwent surgery including pelvic and para-aortic lymphadenectomy and 119 had surgery without lymphadenectomy. Lymph ascites (free intraabdominal fluid or encapsulated pelvic or para-aortic fluid) was assessed by vaginal ultrasound 4-6 weeks postoperatively. Lymphedema was assessed using circumferential measurements of the legs preoperatively and 1 year postoperatively, enabling estimation of leg volume. A BMI-standardized leg volume increase ≥10% was classified as lymphedema. Evaluation of risk factors was performed using multiple logistic regression.
Lymph ascites 4-6-weeks postoperatively occurred in 28.5% (67/235) of the women. The estimated volume of the lymph ascites in these women was mean 28 mL (standard deviation 48 mL) and median 14 mL (interquartile range 2-36 mL). Lymphadenectomy was a risk factor for lymph ascites (aOR 9.97; 95% CI 4.53-21.97) whereas the use of minimally invasive surgery (aOR 0.50; 95% CI 0.25-0.99) reduced the risk. Twenty-two of 231 women (9.5%) developed lymphedema of the legs 1 year after surgery. The presence of lymph ascites was predictive of lymphedema (aOR 3.90; 95% CI 1.52-9.96).
Lymph ascites was common 4-6 weeks after surgery but in a low and clinically insignificant volume. Lymphadenectomy was a strong risk factor for lymph ascites and the use of minimally invasive surgery seemed to reduce the risk. Detection of lymph ascites at early postoperative follow-up may be a means of selecting patients at high risk of developing lymphedema after treatment with endometrial cancer for preventive measures against lymphedema progression.
主要目的是确定子宫内膜癌手术后4 - 6周淋巴腹水的发生率。次要目的是评估淋巴腹水的危险因素以及与腿部淋巴水肿的关联。
这是一项对一项观察性前瞻性多中心研究的事后分析,该研究在14家瑞典医院进行,纳入了2014年6月至2018年1月期间接受早期子宫内膜癌手术的235名女性;116人接受了包括盆腔和腹主动脉旁淋巴结清扫术的手术,119人接受了无淋巴结清扫术的手术。术后4 - 6周通过阴道超声评估淋巴腹水(腹腔内游离液体或包裹性盆腔或腹主动脉旁液体)。术前和术后1年通过测量腿部周长评估淋巴水肿,从而估算腿部体积。体重指数标准化的腿部体积增加≥10%被归类为淋巴水肿。使用多元逻辑回归评估危险因素。
术后4 - 6周,28.5%(67/235)的女性出现淋巴腹水。这些女性淋巴腹水的估计体积平均为28毫升(标准差48毫升),中位数为14毫升(四分位间距2 - 36毫升)。淋巴结清扫术是淋巴腹水的一个危险因素(调整后比值比9.97;95%置信区间4.53 - 21.97),而使用微创手术(调整后比值比0.50;95%置信区间0.25 - 0.99)可降低风险。231名女性中有22人(9.5%)在术后1年出现腿部淋巴水肿。淋巴腹水的存在可预测淋巴水肿(调整后比值比3.90;95%置信区间1.52 - 9.96)。
淋巴腹水在术后4 - 6周很常见,但量少且临床意义不大。淋巴结清扫术是淋巴腹水的一个强危险因素,而使用微创手术似乎可降低风险。术后早期随访中检测到淋巴腹水可能是一种手段,用于选择子宫内膜癌治疗后有发生淋巴水肿高风险的患者,以便采取预防淋巴水肿进展的措施。